Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.220
0.00 (0.00%)
At close: May 23, 2025, 4:00 PM
2.280
+0.060 (2.70%)
After-hours: May 23, 2025, 5:47 PM EDT
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $2.37 million as of May 23, 2025. Its market cap has decreased by -44.98% in one year.
Market Cap
2.37M
Enterprise Value
37.74M
1-Year Change
-44.98%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since October 12, 2017, Venus Concept's market cap has decreased from $278.20M to $2.37M, a decrease of -99.15%. That is a compound annual growth rate of -46.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 3.20M | 18.52% |
| Dec 31, 2024 | 2.70M | -58.46% |
| Dec 29, 2023 | 6.50M | -69.91% |
| Dec 30, 2022 | 21.60M | -76.55% |
| Dec 31, 2021 | 92.10M | 29.35% |
| Dec 31, 2020 | 71.20M | -48.92% |
| Dec 31, 2019 | 139.40M | 687.57% |
| Dec 31, 2018 | 17.70M | -86.70% |
| Dec 29, 2017 | 133.10M | -52.16% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |